J 2018

In Vitro Inhalation Bioaccessibility of Phthalate Esters and Alternative Plasticizers Present in Indoor Dust Using Artificial Lung Fluids

KADEMOGLOU, Aikaterini, Georgios GIOVANOULIS, Anna PALM-COUSINS, Juan Antonio PADILLA-SANCHEZ, Jorgen MAGNER et. al.

Basic information

Original name

In Vitro Inhalation Bioaccessibility of Phthalate Esters and Alternative Plasticizers Present in Indoor Dust Using Artificial Lung Fluids

Authors

KADEMOGLOU, Aikaterini (300 Greece, guarantor, belonging to the institution), Georgios GIOVANOULIS (752 Sweden), Anna PALM-COUSINS (752 Sweden), Juan Antonio PADILLA-SANCHEZ (578 Norway), Jorgen MAGNER (752 Sweden), Cynthia A. DE WIT (752 Sweden) and Christopher D. COLLIN (826 United Kingdom of Great Britain and Northern Ireland)

Edition

ENVIRONMENTAL SCIENCE & TECHNOLOGY LETTERS, WASHINGTON, AMER CHEMICAL SOC, 2018, 2328-8930

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10511 Environmental sciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 6.934

RIV identification code

RIV/00216224:14310/18:00105752

Organization unit

Faculty of Science

UT WoS

000435417000006

Keywords in English

SEMIVOLATILE ORGANIC-COMPOUNDS; DAY-CARE-CENTERS; HUMAN EXPOSURE; FLAME RETARDANTS; RISK-ASSESSMENT; SETTLED DUST; SIZE FRACTION; HUMAN HEALTH; ACID ESTERS; HOUSE DUST

Tags

International impact, Reviewed
Změněno: 2/5/2019 16:26, Mgr. Tereza Miškechová

Abstract

V originále

Phthalate esters (PEs) are used as plasticizers in consumer products. Their low migration stability has resulted in the classification of PEs as major indoor contaminants. Because of PE's ubiquity and adverse health effects on humans and especially children, non-phthalate alternative plasticizers have been introduced into the market. This is the first study of in vitro inhalation bioaccessibility of PEs (e.g., DMP, DEP, and DEHP) and alternative plasticizers (e.g., DEHT and DINCH) via indoor dust to assess inhalation as an alternative route of exposure. Two artificial lung fluids were used, mimicking two distinctively different pulmonary environments: (1) artificial lysosomal fluid (ALF, pH 4.5) representing the intracellular acidic lung fluid inhaled particle contact after phagocytosis by alveolar macrophages and (2) Gamble's solution (pH 7.4), the extracellular healthy fluid for deep lung deposition of dust. DMP and DEP were highly bioaccessible (>75%), whereas highly hydrophobic compounds such as DEHP, DINCH, and DEHT were <5% bioaccessible via both artificial lung fluids. Our findings show that the inhalation bioaccessibility of PEs is primarily governed by their hydrophobicity and water solubility. Further research is necessary to develop unified and biologically relevant inhalation bioaccessibility tests, employed as part of human risk assessment of volatile and semivolatile organic pollutants.